Your browser doesn't support javascript.
loading
Patiromer versus placebo to enable spironolactone use in patients with resistant hypertension and chronic kidney disease (AMBER): a phase 2, randomised, double-blind, placebo-controlled trial.
Agarwal, Rajiv; Rossignol, Patrick; Romero, Alain; Garza, Dahlia; Mayo, Martha R; Warren, Suzette; Ma, Jia; White, William B; Williams, Bryan.
Affiliation
  • Agarwal R; Department of Medicine, Division of Nephrology, Indiana University and Richard L Roudebush VA Medical Center, Indianapolis, IN, USA. Electronic address: ragarwal@iu.edu.
  • Rossignol P; University of Lorraine, Institut National de la Santé et de la Recherche Médicale (Inserm) 1433 CIC-P CHRU de Nancy, Inserm U1116 and French Clinical Research Infrastructure Network INI-CRCT, Nancy, France.
  • Romero A; Medical Affairs, Relypsa, a Vifor Pharma Group Company, Redwood City, CA, USA.
  • Garza D; Clinical Development, Relypsa, a Vifor Pharma Group Company, Redwood City, CA, USA.
  • Mayo MR; Clinical Development, Relypsa, a Vifor Pharma Group Company, Redwood City, CA, USA.
  • Warren S; Clinical Development, Relypsa, a Vifor Pharma Group Company, Redwood City, CA, USA.
  • Ma J; Biometrics, Relypsa, a Vifor Pharma Group Company, Redwood City, CA, USA.
  • White WB; Calhoun Cardiology Center, University of Connecticut School of Medicine, Farmington, CT, USA.
  • Williams B; Institute of Cardiovascular Sciences University College London (UCL) and National Institute for Health Research UCL/UCL Hospitals Biomedical Research Centre, London, UK.
Lancet ; 394(10208): 1540-1550, 2019 10 26.
Article in En | MEDLINE | ID: mdl-31533906

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Polymers / Spironolactone / Diuretics / Hypertension Type of study: Clinical_trials Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Lancet Year: 2019 Document type: Article Country of publication: Reino Unido

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Polymers / Spironolactone / Diuretics / Hypertension Type of study: Clinical_trials Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Lancet Year: 2019 Document type: Article Country of publication: Reino Unido